Replies to post #15038 on Algernon Pharmaceuticals Inc (AGNPF)

[HealthMngr]

True, Novartis makes it, but looks as a license deal with GSK under Brand name Hycamtin. See links below. Could be wrong, no matter...

Also, looks like Novartis just terminated a phase 1b/2 small cell lung cancer trial in August, 2021, so perhaps a great time to partner. There are generics, yet perhaps a combo therapy with a major player could warrant several years of new patent protection for each and a nice partnership agreement for Algernon.

https://adisinsight.springer.com/drugs/800000829

https://en.m.wikipedia.org/wiki/Topotecan#:~:text=After%20GlaxoSmithKline%20received%20final%20FDA,I%20inhibitor%20for%20oral%20use.

https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Topotecan